News - rigosertib

Filter

Current filters:

rigosertib

Popular Filters

Onconova drops Ph III trial of rigosertib in pancreatic cancer

20-12-2013

US biopharma company Onconova Therapeutics says it has discontinued the Phase III ONTRAC study of intravenous…

OncologyOnconova TherapeuticsPharmaceuticalResearchrigosertib

Onconova could file NDA for cancer drug rigosertib next year

Onconova could file NDA for cancer drug rigosertib next year

15-11-2013

Analysts at Edison Equity Research have indicated that US biopharma company Onconova Therapeutics (Nasdaq:…

FinancialOncologyOnconova TherapeuticsPharmaceuticalResearchrigosertibUSA

GVK Biosciences and Onconova in cancer drug development deal

09-01-2013

GVK Biosciences, a Hyderabad, India-based contract research and development organization, and privately-held…

Ex-RADGVK BiosciencesON-013105OncologyOnconova TherapeuticsPharmaceuticalResearchrigosertib

Baxter in up to $565 million deal with Onconova for rigosertib

20-09-2012

US companies Baxter International (NYSE: BAX) and privately-held biotech Onconova Therapeutics have entered…

Baxter InternationalEstybonEuropeLicensingOncologyOnconova TherapeuticsPharmaceuticalrigosertib

Back to top